Afatinib reverses ceritinib resistance (CR) in ALK/ROS1-positive non-small-cell lung cancer cell (NSCLC) via suppression of NRG1 pathway

Chen, H; Zhang, Q; Zhang, Y; Jia, B; Zhang, B; Wang, CL

Wang, CL (reprint author), Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc Tianjin, Dept Lung Canc, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.

ONCOTARGETS AND THERAPY, 2018; 11 (): 8201

Abstract

Background: Lung cancer (LC) is the most prevalent malignancy worldwide, and non-small-cell LC (NSCLC) cell is associated with high mortality. As a me......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索